29.95
29.95 (-2.97%)
As of Mar 06, 2024
Intellia Therapeutics Inc [NTLA]
Source:
Company Overview
Intellia Therapeutics, Inc. is a leading clinical-stage gene editing company, focused on developing potentially curative therapeutics using CRISPR/Cas9-based technologies.
| Country | United States |
| Headquarters | cambridge, massachusetts |
| Phone Number | ( 857 ) 285-6200 |
| Industry | manufacturing |
| CEO | John M. Leonard, M.D |
| Website | www.intelliatx.com |